van family medical semaglutide (@vanfamilymedical) · Van, TX Van Family Medical | Van

Results In the intention-to-treat analysis, dementia risk was not different between GLP1-RA and DPP4i initiators (hazard ratio [HR] 0.95, 95% confidence interval [CI] 0.871.04

Timeline varies significantly based on dosing schedule, baseline metabolic factors, adherence, and individual genetic predispositions in GLP-1 signaling pathways

Sandoz CEO says $40$50 monthly pricing could triple patient access to weight-loss drugs

It is designed to act on two primary receptors involved in glucose and energy regulation

I think to understand GLP1 receptors, we need to discard the old notion that GLP1 is merely a peripheral metabolic hormone